These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 28682102)
1. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats. Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102 [TBL] [Abstract][Full Text] [Related]
2. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol. Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320 [TBL] [Abstract][Full Text] [Related]
3. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning. Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861 [TBL] [Abstract][Full Text] [Related]
10. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839 [TBL] [Abstract][Full Text] [Related]
11. Δ Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177 [TBL] [Abstract][Full Text] [Related]
12. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Jamontt JM; Molleman A; Pertwee RG; Parsons ME Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574 [TBL] [Abstract][Full Text] [Related]
13. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain. Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573 [TBL] [Abstract][Full Text] [Related]
14. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914 [TBL] [Abstract][Full Text] [Related]
15. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination. Zuardi AW; Karniol IG Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104 [TBL] [Abstract][Full Text] [Related]
16. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074 [TBL] [Abstract][Full Text] [Related]
17. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys. Brady KT; Balster RL Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188 [TBL] [Abstract][Full Text] [Related]
18. Interactions between cannabidiol and Δ Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats. Gabaglio M; Zamberletti E; Manenti C; Parolaro D; Rubino T Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445602 [TBL] [Abstract][Full Text] [Related]
20. Effect of prior foot shock stress and Δ Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]